Search results for "PD"

showing 10 items of 1971 documents

Safety and efficacy of anti-PD-1 inhibitor ABBV-181 in lung and head and neck carcinoma

2019

Abstract Background ABBV-181 is a humanized anti-PD1 monoclonal antibody; dose finding and early safety, PK and pharmacodynamic data have been reported (ESMO18). This report summarizes data from the head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC) expansion cohorts in the Ph1 FIH study (NCT03000257). Methods Patients (pts) with previously treated, advanced HNSCC and NSCLC received ABBV-181 IV, 250 mg Q2W or 500 mg Q4W to progression. Response was assessed by RECIST v1.1 and iRECIST. Results As of April 2019, 81 pts were dosed. Table . 1288P n (%) HNSCC n = 41 NSCLC n = 40 Median days on treatment, range 72, 1–407 71, 1–421 Dose: 250 mg/500 mg 31/10 19/21 …

0301 basic medicinemedicine.medical_specialtybusiness.industryAnti pd 1Physical healthStock optionsHematology03 medical and health sciencesNeoplasm progressionDose finding030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinePartial responseMedicinemedicine.symptombusinessHead and neck carcinomaConfusionAnnals of Oncology
researchProduct

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onse…

2018

Background: Primary aim was to investigate the diagnostic value of PAS-positive vacuolated lymphocytes on blood smear in Late Onset Pompe Disease (LOPD) patients and, secondly, to evaluate its potential utility in monitoring treatment effects.Methods: We examined blood smear of 26 LOPD patients. We evaluated 10 treated and 16 untreated LOPD patients. Among the latter group, 7 patients later initiated ERT and were tested again 6 months after start. Blood smear was also sampled from 82 controls and 19 patients with other muscle glycogenoses (MGSDs). PAS staining was used to evaluate: (1) presence of lymphocytes with glycogen-filled vacuoles, (2) quantification of vacuolated lymphocytes.Result…

0301 basic medicinemedicine.medical_specialtytherapeutic monitoringBlood smear; LOPD screening test; PAS-positive lymphocytes; Pompe disease; Therapeutic monitoring; Neurology; Neurology (clinical)Late onsetPeriodic acid–Schiff stainDiseasePAS-positive lymphocytesGastroenterologylcsh:RC346-429Vacuolated Lymphocytes03 medical and health sciences0302 clinical medicineInternal medicineBlood smear; LOPD screening test; PAS-positive lymphocytes; Pompe disease; Therapeutic monitoringmedicineScreening toolLOPD screening testlcsh:Neurology. Diseases of the nervous systemOriginal Researchbusiness.industryPompe diseasePredictive value030104 developmental biologyBlood smearNeurologyblood smearBiomarker (medicine)Neurology (clinical)business030217 neurology & neurosurgeryFrontiers in neurology
researchProduct

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

2016

International audience; Despite effective targeted therapy acting on KIT and PDGFRA tyrosine kinases, gastrointestinal stromal tumors (GIST) escape treatment by acquiring mutations conveying resistance to imatinib mesylate (IM). Following the identification of NKp30-based immunosurveillance of GIST and the off-target effects of IM on NK cell functions, we investigated the predictive value of NKp30 isoforms and NKp30 soluble ligands in blood for the clinical response to IM. The relative expression and the proportions of NKp30 isoforms markedly impacted both event-free and overall survival, in two independent cohorts of metastatic GIST. Phenotypes based on disbalanced NKp30B/NKp30C ratio (Del…

0301 basic medicinemedicine.medical_treatmentImmunologyPDGFRATargeted therapy03 medical and health sciences0302 clinical medicinemedicineImmunology and Allergy[ SDV.IMM ] Life Sciences [q-bio]/ImmunologyneoplasmsOriginal ResearchTumor microenvironmentGiSTbusiness.industryCancermedicine.diseasedigestive system diseases3. Good healthImmunosurveillance030104 developmental biologyImatinib mesylateOncology030220 oncology & carcinogenesisImmunologyCancer research[SDV.IMM]Life Sciences [q-bio]/ImmunologybusinessTyrosine kinase
researchProduct

Immunoistochemical expression of PD-1 and PD-L1 in bone marrow biopsies of patients with acute myeloid leukemia

2020

Background. Haematological and non-haematological malignancies are able to escape the host immune by the capacity to hijack the immune check-points. Several immune check-point molecules are known, such as T cell immunoglobulin mucin-3 (TIM-3), cytotoxic T-cell antigen-4 (CTLA-4), programmed death-1 (PD-1) with its ligand PD-L1 and others.1 The function of these immune check-points is to prevent the damage resulting from an excessive activation of the immune response in the setting of chronic antigenic stimulation, thus leading to autoimmune phenomena, as proved in knock-out mice models. PD-1 is normally present on activated T lymphocytes membrane, acting as a negative costimulatory receptor…

0301 basic medicinemedicine.medical_treatmentvirusesanimal diseaseschemical and pharmacologic phenomena03 medical and health sciences0302 clinical medicinePD-L1Medicinebiologybusiness.industrylcsh:RC633-647.5Myeloid leukemiaHematologyImmunotherapylcsh:Diseases of the blood and blood-forming organsAcute myeloid leukemia Immune check-point blockade Immunotherapy PD-1 PD-L1biochemical phenomena metabolism and nutritionacute myeloid leukemia; immune check-point blockade; PD-1; PD-L1; immunotherapy030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisCancer researchbiology.proteinbacteriaBone marrowbusinessHematology Reports
researchProduct

HSP60 activity on human bronchial epithelial cells

2017

HSP60 has been implicated in chronic inflammatory disease pathogenesis, including chronic obstructive pulmonary disease (COPD), but the mechanisms by which this chaperonin would act are poorly understood. A number of studies suggest a role for extracellular HSP60, since it can be secreted from cells and bind Toll-like receptors; however, the effects of this stimulation have never been extensively studied. We investigated the effects (pro- or anti-inflammatory) of HSP60 in human bronchial epithelial cells (16-HBE) alone and in comparison with oxidative, inflammatory, or bacterial challenges. 16-HBE cells were cultured for 1–4 h in the absence or presence of HSP60, H2O2, lipopolysaccharide (…

0301 basic medicinep38αSettore BIO/17 - IstologiaLipopolysaccharidep38 mitogen-activated protein kinasesImmunologyStimulationBronchip38 Mitogen-Activated Protein KinasesERK1Cell LinePathogenesisMitochondrial Proteins03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOriginal Research ArticlesHumansImmunology and AllergyCOPDInterleukin 8Protein kinase AReceptor16-HBE; COPD; CREB1; ERK1; HSP60; IL-10; IL-8; JNK1; MyD88; NF-κB p65 subunit; TLR-4; p38αPharmacologyIL-8Settore BIO/16 - Anatomia UmanaInterleukin-8JNK1NF-κB p65 subunitEpithelial CellsTLR-4Chaperonin 60MyD88Interleukin-1016-HBEToll-Like Receptor 416-HBE; COPD; CREB1; ERK1; HSP60; IL-10; IL-8; JNK1; MyD88; NF-κB p65 subunit; p38α; TLR-4; Immunology and Allergy; Immunology; PharmacologyInterleukin 10030104 developmental biologychemistry030220 oncology & carcinogenesisIL-10Cancer researchCREB1NF-κB p65 subunitHSP60p38α
researchProduct

Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals

2018

Objective Within the last years, there has been growing awareness of the negative repercussions of unstandardized planning, conduct and reporting of preclinical and biomedical research. Several initiatives have set the aim of increasing validity and reliability in reporting of studies and publications, and publishers have formed similar groups. Additionally, several groups of experts across the biomedical spectrum have published experience and opinion-based guidelines and guidance on potential standardized reporting. While all these guidelines cover reporting of experiments, an important step prior to this should be rigours planning and conduction of studies. The aim of this systematic revi…

0301 basic medicineprotocols & guidelinesData managementValiditylcsh:MedicineEnglish languageRigour03 medical and health sciences0302 clinical medicineEQIPD WP3 study groupProtocol1506030212 general & internal medicineInternal validitydrug evaluation preclinicalProtocol (science)Medical education630 Agriculturebusiness.industrylcsh:RGeneral MedicineBMJOS030104 developmental biologySystematic reviewPsychologybusinessInclusion (education)BMJ Open Science
researchProduct

“Framboisé” spoilage in French ciders: Zymomonas mobilis implication and characterization

2006

Abstract Biodiversity of 17 Zymomonas mobilis strains isolated from French “framboise” ciders from 7 different geographical areas of France was analysed using random amplified polymorphic DNA (RAPD) and 6 different strain fingerprints were observed. One of the fingerprints was identical for 10 of the 17 cases. No correlation between geographical origin and strain fingerprint was observed. In parallel, the cider-making process was followed from the orchard to the final product for Z. mobilis presence. Detection of the bacterium only occurred during the fermentation process. The French isolate, strain AN0101, recently proposed as a novel subspecies ( Z. mobilis subsp. francensis ) was charact…

0303 health sciencesbiologyStrain (chemistry)ZYMOMONAS MOBILIS030306 microbiologyFood spoilage[SDV.IDA] Life Sciences [q-bio]/Food engineeringbiology.organism_classificationZymomonas mobilisRisk zoneRAPD03 medical and health sciencesPolyphenolGROWTH CHARACTERIZATION[SDV.IDA]Life Sciences [q-bio]/Food engineeringBotanyBIODIVERSITYFermentationFood science"FRAMBOISE"BacteriaCIDER-SICKNESS030304 developmental biologyFood ScienceLWT - Food Science and Technology
researchProduct

Alternative NF-κB signaling regulates mTEC differentiation from podoplanin-expressing precursors in the cortico-medullary junction

2015

The thymic epithelium forms specialized niches to enable thymocyte differentiation. While the common epithelial progenitor of medullary and cortical thymic epithelial cells (mTECs and cTECs) is well defined, early stages of mTEC lineage specification have remained elusive. Here, we utilized in vivo targeting of mTECs to resolve their differentiation pathways and to determine whether mTEC progenitors participate in thymocyte education. We found that mTECs descend from a lineage committed, podoplanin (PDPN)-expressing progenitor located at the cortico-medullary junction. PDPN(+) junctional TECs (jTECs) represent a distinct TEC population that builds the thymic medulla, but only partially supp…

0303 health scienceseducation.field_of_studyImmunologyPopulationGene targetingBiologyCell biology03 medical and health sciencesThymocyte0302 clinical medicinePodoplaninImmunologyImmunology and AllergyCentral toleranceProgenitor celleducationPDPN030304 developmental biology030215 immunologyProgenitorEuropean Journal of Immunology
researchProduct

A continuous time tug-of-war game for parabolic $p(x,t)$-Laplace type equations

2019

We formulate a stochastic differential game in continuous time that represents the unique viscosity solution to a terminal value problem for a parabolic partial differential equation involving the normalized $p(x,t)$-Laplace operator. Our game is formulated in a way that covers the full range $1<p(x,t)<\infty$. Furthermore, we prove the uniqueness of viscosity solutions to our equation in the whole space under suitable assumptions.

050208 financeLaplace transformApplied MathematicsGeneral MathematicsTug of warProbability (math.PR)010102 general mathematics05 social sciencesMathematical analysisType (model theory)01 natural sciencesParabolic partial differential equationTerminal valueMathematics - Analysis of PDEs0502 economics and businessDifferential gameFOS: Mathematics91A15 49L25 35K650101 mathematicsViscosity solutionMathematics - ProbabilityAnalysis of PDEs (math.AP)Mathematics
researchProduct

Observation of $Z$ production in proton-lead collisions at LHCb

2014

The first observation of $Z$ boson production in proton-lead collisions at a centre-of-mass energy per proton-nucleon pair of $\sqrt{s_{NN}}=5~\text{TeV}$ is presented. The data sample corresponds to an integrated luminosity of $1.6~\text{nb}^{-1}$ collected with the LHCb detector. The $Z$ candidates are reconstructed from pairs of oppositely charged muons with pseudorapidities between 2.0 and 4.5 and transverse momenta above $20~\text{GeV}/c$. The invariant dimuon mass is restricted to the range $60-120~\text{GeV}/c^2$. The $Z$ production cross-section is measured to be \begin{eqnarray*} ��_{Z\to��^+��^-}(\text{fwd})&amp;=&amp;13.5^{+5.4}_{-4.0}\text{(stat.)}\pm1.2\text{(syst.)}~\text{nb} …

14.70.Hp - Z bosonProtonNuclear Theory01 natural sciencesPhysics Particles & FieldsHigh Energy Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareLuminosityHigh Energy Physics - Experiment (hep-ex)Heavy-ion collision[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Electroweak interaction; Forward physics; Heavy Ions; Heavy-ion collision; Particle and resonance productionElectroweak interactionHeavy IonsHeavy IonNuclear ExperimentQCBosonPhysics25.75.Dw - Relativistic heavy-ion collisions: Particle and resonance production; 14.70.Hp - Z bosons; 13.38.Dg - Decays of Z bosons; 12.15.-y - Electroweak interactionsPhysicsHIGH ENERGIES12.15.-y - Electroweak interactionsParticle physicsComputer Science::Computation and Language (Computational Linguistics and Natural Language and Speech Processing)13.38.Dg - Decays of Z bosons25.75.Dw - Relativistic heavy-ion collisions: Particle and resonance productionPhysical SciencesPARTON DISTRIBUTIONS; BOSON PRODUCTION; HIGH ENERGIES; NUCLEAR PDFS; DEUTERIUM; DECAYFísica nuclearProduction (computer science)14.70.Hp - Z bosonsParticle Physics - ExperimentNuclear and High Energy PhysicsParticle physicsNUCLEAR PDFS530 PhysicsDEUTERIUMFOS: Physical sciencesPhysics InstituteLHCb - Abteilung HofmannHadronsParticle and resonance production0103 physical sciencesElectroweak interaction; Forward physics; Heavy Ions; Heavy-ion collision; Particle and resonance production; Nuclear and High Energy PhysicsSDG 7 - Affordable and Clean Energy010306 general physicsForward physicLarge Hadron Collider (France and Switzerland)BOSON PRODUCTION/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyScience & TechnologyMuon010308 nuclear & particles physicshep-exComputer Science::Information RetrievalGran Col·lisionador d'Hadrons13.38.Dg - Decays of Z bosonPARTON DISTRIBUTIONSForward physicsHigh Energy Physics::ExperimentFísica de partículesExperimentsDECAYEnergy (signal processing)JHEP
researchProduct